These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 13329939)

  • 41. Treatment of diabetes mellitus with BZ-55.
    CHARLES B
    Can Med Assoc J; 1956 Jun; 74(12):985-7. PubMed ID: 13329951
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical response to BZ-55.
    SPAULDING WB
    Can Med Assoc J; 1956 Jun; 74(12):992-4. PubMed ID: 13329955
    [No Abstract]   [Full Text] [Related]  

  • 43. The relation of various variables to the hypoglycemic action of 1-butyl-3-p-tolylsulfonylurea in patients with diabetes mellitus.
    DIENGOTT D; DOLGER H; MIRSKY IA
    Metabolism; 1956 Nov; 5(6 Part 2):875-93. PubMed ID: 13378057
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment of unstable diabetes mellitus with BZ-55 and insulin.
    WATT JG
    Can Med Assoc J; 1956 Jun; 74(12):983-5. PubMed ID: 13329950
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical experience with carbutamide (BZ-55); a progress report.
    CAMERINI-DAVALOS R; MARBLE A; ROOT HF
    Diabetes; 1957; 6(1):74-7; discussion, 85-90. PubMed ID: 13397432
    [No Abstract]   [Full Text] [Related]  

  • 46. [First results of the treatment of diabetes by BZ 55].
    Klotz HP; Avril J; Israel L; Gorins L
    Bull Mem Soc Med Hop Paris; 1956; 72(14-15):453-5. PubMed ID: 13342945
    [No Abstract]   [Full Text] [Related]  

  • 47. BZ 55 in diabetes.
    MCKENZIE JM; MARSHALL PB; STOWERS JM; HUNTER RB
    Br Med J; 1956 Aug; 2(4990):448-51. PubMed ID: 13342510
    [No Abstract]   [Full Text] [Related]  

  • 48. Preliminary experience with BZ-55.
    HALL WE; LITTLE JA; O'SULLIVAN MO
    Can Med Assoc J; 1956 Jun; 74(12):991-2. PubMed ID: 13329954
    [No Abstract]   [Full Text] [Related]  

  • 49. [Oral treatment of diabetes mellitus with D-860, a new hypoglycemic but not sulfonamidic drug; clinical study of 90 cases].
    INTROZZI P; MARIGO S
    Prog Med (Napoli); 1956 Sep; 12(17):513-27. PubMed ID: 13379550
    [No Abstract]   [Full Text] [Related]  

  • 50. The value of BZ 55 in control of diabetes.
    MURRAY I; WANG I
    Br Med J; 1956 Aug; 2(4990):452-4. PubMed ID: 13342512
    [No Abstract]   [Full Text] [Related]  

  • 51. [An effective peroral anti-diabetic drug (BZ 55)].
    BERTRAM F; BENDFELDT E; OTTO H
    Dtsch Med Wochenschr; 1955 Oct; 80(40):1455-60. PubMed ID: 13261733
    [No Abstract]   [Full Text] [Related]  

  • 52. The effect of BZ-55 on biochemically uncontrolled diabetes without insulin treatment.
    LEIBEL BS
    Can Med Assoc J; 1956 Jun; 74(12):979-82. PubMed ID: 13329949
    [No Abstract]   [Full Text] [Related]  

  • 53. Sudden death in a diabetic subject during treatment with BZ-55 (carbutamide).
    FEDERMAN DD; FIELD JB
    Diabetes; 1957; 6(1):67-70; discussion, 85-90. PubMed ID: 13397429
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of BZ-55 on the insulin tolerance curve.
    SMITH GW; KUMAR D
    Can Med Assoc J; 1956 Jun; 74(12):997. PubMed ID: 13329957
    [No Abstract]   [Full Text] [Related]  

  • 55. [Oral therapy of diabetes mellitus by N-tolyl-sulfonyl-N'-butyl urea (D 860); clinical and experimental studies].
    BANDER A; CREUTZFELDT W; DORFMULLER T; EHRHART H; MARX R; MASKE H; MEIER W; MOHNIKE G; PFEIFFER EF; SCHLAGINTWEIT S; SCHOFFLING K; SCHOLZ J; SEIDLER I; STEIGERWALD H; STICH W; STOTTER G; ULRICH H
    Dtsch Med Wochenschr; 1956 May; 81(21):823-46; contd. PubMed ID: 13330473
    [No Abstract]   [Full Text] [Related]  

  • 56. BZ 55 and D 860 in the treatment of diabetes mellitus.
    SCHNEIDER T; POLITZER WM
    S Afr Med J; 1957 Feb; 31(7):142-6. PubMed ID: 13409061
    [No Abstract]   [Full Text] [Related]  

  • 57. [Treatment of ten cases of diabetes with oral hypoglycemic sulfonamide BZ 55 or nadisan].
    FERNANDEZ BASABE E; GALAN J; OLIVER A; OLIVER-PASCUAL E; PURAS E
    Rev Esp Enferm Apar Dig Nutr; 1956; 15(2):478-88. PubMed ID: 13370980
    [No Abstract]   [Full Text] [Related]  

  • 58. [The current place of hypoglycemic sulfonamides (BZ 55) and similar products (D 860) in diabetic control].
    BASTENIE PA
    Brux Med; 1957 Mar; 37(13):499-506. PubMed ID: 13426651
    [No Abstract]   [Full Text] [Related]  

  • 59. The effect of BZ-55 (carbutamide) on glucose-6-phosphatase activity.
    HAWKINS RD; ASHWORTH MA; HAIST RE
    Can Med Assoc J; 1956 Jun; 74(12):972-3. PubMed ID: 13329945
    [No Abstract]   [Full Text] [Related]  

  • 60. An effect of BZ-55 (carbutamide) on the rate of absorption of glucose from the gastrointestinal tract.
    FRIEDLICH TL; ASHWORTH MA; HAWKINS RD; HAIST RE
    Can Med Assoc J; 1956 Jun; 74(12):973-4. PubMed ID: 13329946
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.